MarginsXMarginsX
Home › Markets › Health Care › RTSN

Retension Pharmaceuticals Inc. (RTSN)

RTSN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$11.46
-6.60% on the day
Market cap
$90.3M
Micro cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerRTSN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2026
SEC CIK0002002988
SEC industry codePharmaceutical Preparations (SEC code, stale: periodic reports ended never filed)
Incorporated inDE

Financials

New registrant: no annual report filed under this company yet.

Warning signs

Cash runway
no XBRL financials
Share count, 1 year
No year-earlier count
Going-concern doubt
No recent 10-K, 10-Q or 20-F
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo recent periodic reportNone on EDGAR
Cash and burnno XBRL financialsNone on EDGAR
Shares outstandingNo cover-page share count in XBRLNone on EDGAR
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWolf & Company, P.C., Boston, Massachusetts, United StatesPCAOB Form AP 2026-10-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
SEC reportingThe company has never filed a periodic report with the SEC, so its SEC industry code was never reviewed against one.None on EDGAR

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B42026-10-09
Latest current report
CURRENT REPORT
8-K2026-10-23

Source: SEC EDGAR submissions feed, 45 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+11.1%
1 month+5.5%
3 monthsNot enough price history
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high-24.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
PMVPPMV Pharmaceuticals Inc.$1.19-6.30%$89.9M
NBPNovaBridge Biosciences$0.7915-6.87%$91.3M
ANIXAnixa Biosciences Inc.$2.55-2.67%$88.6M
HURATuHURA Biosciences Inc.$1.33-4.32%$87.5M
KZIAKazia Therapeutics Limited$5.60-15.41%$87.1M
NRXPNRX Pharmaceuticals Inc.$2.15-1.83%$93.8M
GNLXGenelux Corporation$1.92+2.95%$86.9M
NKTXNkarta Inc.$1.21+1.68%$86.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier